News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Cambrex Corporation To Stop Acquisition Plan, CEO To Leave
January 5, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Jan 4 (Reuters) - Cambrex Corp. (CBM.N: Quote, Profile, Research) on Wednesday said Chief Executive and President John Leone will leave the company effective Jan. 15 and it would discontinue its acquisition plan.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoff Tracker
Caribou layoffs could wipe out 90% of staff
October 9, 2026
·
101 min read
·
BioSpace Editorial Staff
IPO
TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms
October 9, 2026
·
3 min read
·
Gabrielle Masson
Deals
Viatris inks $1.65B Pacira buyout to build non-opioid pain therapy business
October 9, 2026
·
2 min read
·
Nick Paul Taylor
Editorial
Eli Lilly and the LA Dodgers: A tale of 2 dynasties
October 8, 2026
·
3 min read
·
Heather McKenzie
